Randall K. Johnson

77 year

Health Technology

Profile

Randall K.
Johnson worked as an Independent Director at Callisto Pharmaceuticals, Inc. from 2005 to 2013.
Prior to that, he was the Group Director of the Oncology Research Department at GSK Plc from 1982 to 2002.
He also held the same position at Smithkline Beecham Pharmaceuticals (Canada).

Former positions of Randall K. Johnson

Companies	Position	End
Callisto Pharmaceuticals, Inc. Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY.	Director/Board Member	21/01/2013
GSK PLC	Corporate Officer/Principal	31/01/2002
Smithkline Beecham Pharmaceuticals (Canada)	Corporate Officer/Principal	-

See the detail of Randall K. Johnson's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Randall K. Johnson's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
GSK PLC	Health Technology

Private companies	2
Callisto Pharmaceuticals, Inc. Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY.	Health Technology
Smithkline Beecham Pharmaceuticals (Canada)